Skip to main content Help with accessibility Skip to main navigation

LUSUTROMBOPAG tablets (Mulpleo®▼) for treating severe thrombocytopenia in adults with chronic liver disease having planned invasive procedures

CCG Approval Status:

Date Added: 30 - Jan - 2020
Red

The Pan Mersey Area Prescribing Committee recommends the prescribing of LUSUTROMBOPAG tablets (Mulpleo®▼), by specialists only, for treating severe thrombocytopenia in adults with chronic liver disease having planned invasive procedures in accordance with NICE TA617